Literature DB >> 33433315

A case report of metastatic renal cell carcinoma causing corticobasal syndrome.

Melanie P Jensen, James B Rowe, Kieren S J Allinson.   

Abstract

We present a case report of a patient with a history of renal cell carcinoma in which corticobasal syndrome had been diagnosed ante-mortem. However, distinguishing features of corticobasal degeneration pathology were absent at post-mortem. Instead, neuropathological examination revealed features consistent with the patient's history of renal cell carcinoma: micrometastatic renal cell carcinoma in cerebellar and cerebral white matter, including within the gyral white matter of the primary motor and somatosensory cortices. There was also Purkinje cell loss and mild lymphocytic inflammation in the cerebellum, but the significance of this was unclear. A number of "corticobasal degeneration mimics" have been described in the literature, but micrometastatic carcinoma causing corticobasal syndrome is a novel finding. This case expands the range of clinical disorders which may mimic corticobasal degeneration to include micrometastatic carcinoma.

Entities:  

Mesh:

Year:  2021        PMID: 33433315      PMCID: PMC7611575          DOI: 10.5414/NP301343

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  7 in total

1.  Criteria for the diagnosis of corticobasal degeneration.

Authors:  Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner
Journal:  Neurology       Date:  2013-01-29       Impact factor: 9.910

2.  Renal cell carcinomas mass of <4 cm are not always indolent.

Authors:  Nessn H Azawi; Lars Lund; Mikkel Fode
Journal:  Urol Ann       Date:  2017 Jul-Sep

Review 3.  Corticobasal syndrome: A diagnostic conundrum.

Authors:  Jacy Bezerra Parmera; Roberta Dieh Rodriguez; Adalberto Studart Neto; Ricardo Nitrini; Sonia Maria Dozzi Brucki
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec

Review 4.  Corticobasal degeneration and corticobasal syndrome: A review.

Authors:  Vasilios C Constantinides; George P Paraskevas; Panagiotis G Paraskevas; Leonidas Stefanis; Elisabeth Kapaki
Journal:  Clin Park Relat Disord       Date:  2019-08-30

5.  MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.

Authors:  Zhuxian Zhou; Mohammed Qutaish; Zheng Han; Rebecca M Schur; Yiqiao Liu; David L Wilson; Zheng-Rong Lu
Journal:  Nat Commun       Date:  2015-08-12       Impact factor: 14.919

6.  Validation of the new consensus criteria for the diagnosis of corticobasal degeneration.

Authors:  S K Alexander; T Rittman; J H Xuereb; T H Bak; J R Hodges; J B Rowe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-02-12       Impact factor: 10.154

Review 7.  Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.

Authors:  Anand Venkatraman; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2016-06-30       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.